Specific Lipoprotein(a) apheresis attenuates progression of carotid intima-media thickness in coronary heart disease patients with high lipoprotein(a) levels
- 1 May 2015
- journal article
- clinical trial
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 18, 163-169
Abstract
No abstract availableKeywords
Funding Information
- Moscow State Government (8/3-284n-10)
This publication has 26 references indexed in Scilit:
- Lipoprotein Apheresis in Patients With Maximally Tolerated Lipid-Lowering Therapy, Lipoprotein(a)-Hyperlipoproteinemia, and Progressive Cardiovascular DiseaseCirculation, 2013
- Effect of specific lipoprotein(a) apheresis on coronary atherosclerosis regression assessed by quantitative coronary angiographyAtherosclerosis Supplements, 2013
- Lipoprotein(a) as a cardiovascular risk factor: current statusEuropean Heart Journal, 2010
- Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular MortalityJAMA, 2009
- Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial InfarctionJAMA, 2009
- Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary eventsNature Reviews Cardiology, 2009
- Use of Carotid Ultrasound to Identify Subclinical Vascular Disease and Evaluate Cardiovascular Disease Risk: A Consensus Statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force Endorsed by the Society for Vascular MedicineJournal of the American Society of Echocardiography, 2008
- Elevated Lipoprotein(a) does not promote early atherosclerotic changes of the carotid arteries in young, healthy adultsAtherosclerosis, 2007
- Relation Between Lipoprotein(a) and Fibrinogen and Serial Intravascular Ultrasound Plaque Progression in Left Main Coronary ArteriesJACC, 2006
- Role of Lipoprotein(a) and Apolipoprotein(a) Phenotype in AtherogenesisCirculation, 1999